As of 04 Nov 2026 16:35 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2022/054 (06 Jun 2022): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Hydrocortisone 2.5mg muco-adhesive buccal tabletsaffected product · inferred from phrasing | Out of stock, as stated | w/c 5th September 2022precision: a month · window end 11 Sep 2022, derived from “w/c 5th September 2022” | notice of 06 Jun 2022 |
| Betamethasone soluble tablets for off-label topical use in the treatment of aphthous ulcersnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 06 Jun 2022 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Betamethasone soluble tablets for off-label topical use in the treatment of aphthous ulcers — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Hydrocortisone
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026. chemical 'Hydrocortisone' appears under 2 BNF codes; 0603020J0 (most presentations) taken.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 06 Jun 2022. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 06 Jun 2022 | Medicine Supply Notification: Hydrocortisone 2.5mg Muco-Adhesive Buccal Tablets | Supply notification | Tier 2 | MSN/2022/054 |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2022)3 Hydrocortisone 2.5mg Muco-Adhesive Buccal Tablets · issued 29 Jul 2022 · valid until w/c 5th September 2022, as stated · matched by name PDF ↗
- MSAN(2021)21 Gentisone HC® (Gentamicin 0.3% w/v and Hydrocortisone acetate 1% w/v) Ear · issued 03 Aug 2021 · valid until w/c 25th October 2021, as stated · matched by name PDF ↗